| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $274.8M | -7.7% |
| Cost of Revenue | $81.1M | -15.8% |
| Gross Profit | $193.7M | -3.9% |
| R&D Expense | $47.4M | -4.1% |
| SG&A Expense | $49.5M | -19.3% |
| Operating Income | -$102.3M | +37.6% |
| Pre-tax Income | -$110.1M | +39.6% |
| Income Tax | $2.6M | +205.9% |
| Net Income | -$112.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.4M | -76.1% |
| Accounts Receivable | $38.6M | -0.3% |
| Current Assets | $118.4M | -60.6% |
| Total Assets | $529.5M | -39.1% |
| Current Liabilities | $120.4M | -7.8% |
| Long-term Debt | $290.2M | -39.1% |
| Total Liabilities | $424.6M | -32.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.2M | -51.5% |
| Capital Expenditures | $882K | -27.7% |
| Investing Cash Flow | -$882K | +27.7% |
| Financing Cash Flow | -$202.3M | -229.6% |
| Free Cash Flow | $23.4M | -52.1% |
| +37.3% |
| EPS (Basic) | -$4.26 | +26.2% |
| EPS (Diluted) | -$4.26 | +26.2% |
| Stockholders' Equity |
| -$18.3M |
| -114.5% |